Related by context. All words. (Click for frequent words.) 71 Onconase 70 JAK inhibitor 70 Aplidin 70 ATL/TV# 70 Archexin 70 vascular disrupting agent 70 Ceflatonin 70 YONDELIS 70 ATL# [001] 69 favorable pharmacokinetic profile 69 preclinically 69 cannabinor 69 Anavex #-# 69 Virulizin ® 69 CBLC# 69 Mipomersen 69 Phase Ib clinical 68 adipiplon 68 Lu AA# 68 mertansine 68 ProSavin 68 Panzem 68 GRN# 68 phase IIa clinical 68 ENMD # 68 triphendiol 68 SNT MC# 68 oral prodrug 68 GLYX 68 XmAb# 67 HuMax EGFr 67 Pimavanserin 67 Prodarsan ® 67 alvespimycin 67 DXL# 67 anti amnesic 67 Spiegelmer ® 67 Azedra 67 riociguat 67 intranasal formulation 67 NP2 Enkephalin 67 receptor tyrosine kinase inhibitor 67 Tyrima 67 Bicifadine 67 Removab 67 OncoGel 67 protein kinase inhibitor 67 lumiliximab 67 Cogane 67 enzastaurin 67 ADAGIO study 67 Valdoxan 67 OncoVEX 67 farletuzumab 67 KRN# 67 INCB# [001] 66 Exherin TM 66 HQK 66 ganetespib 66 metaglidasen 66 R#/MEM # 66 favorable tolerability 66 CGEN # 66 PXD# 66 VA# [002] 66 PSMA ADC 66 Cinquil 66 AEG# 66 photoprotective drug 66 ANAVEX #-# [001] 66 Annamycin 66 KNS # 66 HuMax CD4 66 Safinamide 66 AZILECT ® 66 UPLYSO 66 S/GSK# 66 MAGE A3 ASCI 66 Rasagiline 66 Sym# 66 vemurafenib 66 trastuzumab DM1 66 Firazyr 66 tezampanel 66 SUTENT ® 66 liposomal formulation 66 Phase #b/#a 66 OncoVEX GM CSF 66 BrachySil TM 66 rEV# 66 BEMA TM Fentanyl 66 flavopiridol 66 entinostat 66 Xanafide 66 BZL# 66 EndoTAG TM -1 66 Zybrestat 66 preclinical efficacy 66 SAR# [004] 66 anticancer agent 66 Darinaparsin 66 partial agonist 66 Phase Ib study 66 obatoclax 66 IMA# 66 OHR/AVR# 66 mapatumumab 66 Abiraterone 66 BRAF inhibitors 66 phase IIa 65 PDE4 inhibitor 65 rufinamide 65 Silodosin 65 methylnaltrexone 65 OMP #M# 65 phase IIb trial 65 Golimumab 65 bortezomib Velcade 65 multitargeted 65 PEGylated interferon 65 Traficet EN 65 Zolinza 65 SRT# [003] 65 clobazam 65 Fibrillex 65 TG# [003] 65 dacetuzumab 65 ALGRX 65 Nanobody 65 HGS# 65 PROCHYMAL 65 tipifarnib 65 Exelixis compounds 65 Zoraxel 65 phase Ib 65 Cloretazine 65 silodosin 65 Vilazodone 65 GLP toxicology studies 65 ARIKACE ™ 65 angiogenesis inhibitor 65 teriflunomide 65 OXi# 65 M6G 65 vascular disrupting agents 65 pharmacokinetic PK study 65 Corlux 65 midstage trials 65 EndoTAGTM 1 65 indibulin 65 GAP #B# 65 Curaxin 65 pertuzumab 65 Nanobody ® 65 phase IIb clinical 65 PhG alpha 1 65 GLPG# 65 BRAF inhibitor 65 CYT# 65 MS spasticity 65 immune modulating 65 mTOR inhibition 65 vidofludimus 65 samalizumab 65 CRD5 65 tanespimycin 65 OvaRex R 65 CLORETAZINE TM VNP#M 65 Phase #b/#a clinical 65 Lupuzor 65 antitumor effects 65 AVN# [001] 65 selective modulator 65 NV1FGF 65 Tasimelteon 65 CCR5 inhibitor 65 DACH platinum 65 afamelanotide 65 Romidepsin 65 Pertuzumab 65 mGluR2 NAM 64 ONCONASE R 64 CA4P 64 radiation sensitizer 64 antitumor 64 Guanilib 64 ELACYT 64 Insegia 64 RhuDex 64 PEG SN# 64 MAP# 64 MGd 64 Panzem R NCD 64 Gleevec resistant 64 HuLuc# 64 Pemetrexed 64 erlotinib Tarceva 64 anticancer activity 64 ASONEP 64 RGB # 64 forodesine 64 Cloretazine R 64 huC# DM4 64 Serdaxin 64 Carfilzomib 64 ReN# 64 BrachySil 64 Quinamed 64 gepirone ER 64 Factor VIIa 64 Angiocept 64 eniluracil 64 midstage clinical 64 Proxinium TM 64 ToGA 64 orally bioavailable 64 Phase IIIb clinical 64 PSN# [002] 64 Sphingomab 64 RhuDex ® 64 orally dosed 64 TLK# 64 ixabepilone 64 vascular disrupting 64 Symadex 64 oral antiviral 64 CEQ# 64 almorexant 64 fosbretabulin 64 OvaRex ® MAb 64 novel VDA molecule 64 bortezomib Velcade ® 64 Androxal TM 64 GSK# [001] 64 anti CD3 antibody 64 OncoVex 64 Pazopanib 64 LEP ETU 64 cytostatic 64 omega interferon 64 Catena ® 64 Ophena TM 64 DAVANAT 64 ralfinamide 64 Serdolect ® 64 Abbokinase 64 refractory prostate cancer 64 Trofex 64 Ampakine 64 Degarelix 64 Hsp# inhibitor 64 therapeutic monoclonal antibody 64 Iloperidone 64 OMNARIS HFA 64 pomalidomide 64 SYN# 64 depsipeptide 64 antidepressant efficacy 64 miglustat 64 Plicera 64 Proellex TM 64 ruxolitinib 64 canakinumab 64 antiangiogenesis 64 elacytarabine 64 RPL# 64 inhibit metastasis 64 safinamide 64 perampanel 64 inecalcitol 64 imexon 64 AKT inhibitor 64 Phase 1a clinical 64 Revlimid lenalidomide 64 Omnitarg 64 Azedra TM 64 ESBA# 64 pharmacodynamic properties 64 Crofelemer 64 Reolysin 64 PCK# 64 histone deacetylase inhibitor 64 Orazol 64 pharmacodynamic effects 64 Tarvacin 64 tipranavir 64 Plenaxis TM 64 R#/MEM 64 drug GAP #B# 64 ACAPODENE 64 PSN# [001] 64 TOLAMBA 64 LHRH agonists 64 anticancer compound 64 Aflibercept 64 Ambrisentan 64 BAL# [002] 64 Phase IIb III 64 romidepsin 64 recurrent herpes labialis 64 CXB# 63 Preclinical studies 63 TRO# 63 GAMMAGARD 63 elotuzumab 63 ATL# [002] 63 eprotirome 63 novel anticancer 63 TBC# 63 mTOR inhibitors 63 MyVax 63 epothilones 63 solithromycin 63 Vandetanib 63 trastuzumab Herceptin 63 Fampridine 63 vivo potency 63 bicifadine 63 aurora kinase 63 tezampanel NGX# 63 thalidomide Thalomid 63 dexanabinol 63 torezolid phosphate 63 Anthim 63 cMET 63 Temsirolimus 63 receptor inhibitor 63 rxRNA 63 HuMax CD# 63 Dasatinib 63 Dacogen decitabine 63 Tarvacin TM 63 MGCD# [001] 63 Bifeprunox 63 Amrubicin 63 amrubicin 63 diabetic neuropathic pain 63 Panzem NCD 63 antiresorptive 63 FOLOTYN ® 63 YONDELIS R 63 Preclinical studies suggest 63 CCX# 63 tyrosine kinase inhibitor 63 anti EGFR antibody 63 PEGPH# 63 ACV1 63 Pyridorin 63 pan HDAC inhibitor 63 Amplimexon 63 targeted radiotherapeutic 63 ganaxolone 63 Interferon alpha 63 oral FTY# 63 immune modulatory 63 CYT# potent vascular disrupting 63 Enzastaurin 63 PRT# 63 davunetide intranasal AL 63 Omacetaxine 63 Elocalcitol 63 phase IIb III 63 potent antiproliferative 63 budesonide foam 63 ICA # 63 TRV# [001] 63 APOPTONE 63 potent antitumor activity 63 JP-#/fipamezole 63 DDP# 63 Cloretazine ® 63 EOquin TM 63 MYDICAR ® 63 pharmacodynamic PD 63 ospemifene 63 Atiprimod 63 bardoxolone methyl 63 GMX# 63 Tarceva TM 63 masitinib 63 AP# [003] 63 Mitoxantrone 63 reslizumab 63 Arranon 63 baminercept 63 tafamidis 63 IL# PE#QQR 63 Luteinizing Hormone Releasing Hormone 63 generation purine nucleoside 63 MEK inhibitor 63 LCP AtorFen 63 PDE# inhibitors 63 PF # [002] 63 AMD# [003] 63 Aurora kinase inhibitor 63 REOLYSIN ® 63 etanercept Enbrel 63 Bicalutamide 63 ponatinib 63 pharmacological chaperone 63 Saforis 63 CCR9 antagonist 63 axitinib 63 vismodegib 63 proteasome inhibitor 63 TELINTRA 63 glucokinase activator 63 KIACTA ™ 63 potency selectivity 63 SERCA2a 63 Davanat 63 Cannabinor 63 Menerba 63 Aviptadil 63 MEK inhibitors 63 tumor vascular disrupting 63 multicenter Phase II 63 Diamyd ® 63 CDK inhibitors 63 Tesetaxel 63 EP #R 63 tramiprosate 63 efaproxiral 63 AOD# [002] 63 histamine dihydrochloride 63 Phase IIB 63 Levetiracetam 63 Deforolimus 63 anti leukemic 63 DermaVir Patch 63 ANAVEX #-# [003] 63 ISIS # 63 Rezular 63 Fulvestrant 63 CORT # 63 Epratuzumab 63 Alpharadin 63 Neurodex 63 Clonicel 63 Bezielle 63 pharmacokinetic characteristics 63 VIR# 63 antiangiogenic agent 63 BrachySil ™ 63 vorinostat 63 GSK# [002] 63 #I TM# 63 CINOD 63 SGS# 63 Nebido 62 AEGR 62 SU# [003] 62 LY# [003] 62 tasimelteon 62 cediranib 62 mGluR5 NAM 62 GRN#L 62 G#DT 62 docetaxel Taxotere ® 62 CG# [003] 62 histone deacetylase HDAC inhibitor 62 Memryte 62 selective androgen receptor modulator 62 antiproliferative effects 62 demonstrated antitumor activity 62 favorable pharmacokinetic 62 oral anticancer 62 GRNVAC1 62 antitumor effect 62 alagebrium 62 Phase IIA 62 Hedgehog antagonist 62 Lixivaptan 62 THR beta agonist 62 DP b# 62 Varespladib 62 CA9 SCAN 62 Fx #A 62 Phase #b/#a trial 62 Xerecept 62 Ocrelizumab 62 Urocidin 62 JAK2 inhibitor 62 nalbuphine ER 62 CRLX# 62 TriRima 62 anti angiogenic agent 62 Forodesine HCl 62 Glypromate 62 radiolabeled TM# 62 AZILECT R 62 velafermin 62 CytoFabTM 62 iroxanadine 62 Alvesco R 62 chemopreventive agent 62 Pregabalin 62 PRTX 62 CYC# 62 JAK inhibitors 62 IRX 2 62 calcitonin 62 zileuton 62 NVA# 62 TLR9 agonist 62 Phase 1b trial 62 Huntexil 62 Erlotinib 62 Daclizumab 62 Zemplar Capsules 62 SILENOR 62 ANG# 62 PBT2 62 desvenlafaxine 62 tesmilifene 62 sd rxRNA 62 Fingolimod 62 regorafenib 62 CCR5 antagonist 62 Pharmacokinetic studies 62 fibrotic disease 62 palonosetron 62 mecamylamine 62 QRxPharma 62 Vernakalant 62 GeneICE 62 omacetaxine mepesuccinate 62 NasalFent 62 PD LID 62 HCV protease inhibitors 62 Squalamine 62 Campath alemtuzumab 62 ThGRF 62 systemically administered 62 bardoxolone 62 EOquin 62 apoptosis inducer 62 Nuedexta 62 placebo controlled clinical 62 LT NS# 62 intranasal delivery 62 Aurexis 62 Octreotide 62 systemic RNAi 62 Prestara 62 Chemophase 62 tiapamil 62 atrasentan 62 Fentanyl TAIFUN R 62 Omapro 62 ON #.Na 62 BioNumerik 62 chimeric monoclonal antibody 62 ziconotide 62 lintuzumab 62 secretin 62 Crizotinib 62 non nucleoside 62 Gaboxadol 62 Thiovir 62 Muraglitazar 62 rALLy trial 62 CIMZIA ™ 62 investigational humanized monoclonal antibody 62 oral methylnaltrexone 62 telomerase inhibitor 62 galiximab 62 casopitant 62 Provecta 62 gaboxadol 62 potent anticancer 62 Lamotrigine 62 CDP# 62 5 HT6 receptor 62 compound AEZS 62 Alzhemed TM 62 omacetaxine 62 novel prodrug 62 MAXY G# 62 RezularTM 62 successfully commercialize Iluvien 62 GFT# 62 Ramoplanin 62 docetaxel Taxotere 62 tubulin inhibitor 62 Alocrest 62 DCCR 62 VNP#M 62 NeuVax 62 Oglemilast 62 trodusquemine 62 Enzyme Replacement Therapy 62 adrenergic regulation 62 PI3K inhibitor 62 eltrombopag 62 nanopharmaceutical 62 PLX# 62 Cytolin ® 62 Curaxin CBLC# 62 Darusentan 62 Atrasentan 62 evaluating tivozanib 62 SCENESSE ® 62 PHX# 62 brivaracetam 62 Kahalalide F 62 Blinatumomab 62 zanolimumab 62 lorvotuzumab mertansine 62 Phase IIb clinical trials 62 chemotherapeutic drug 62 Capesaris 62 Triolex 62 proteasome inhibitors 62 LAF# 62 Neuradiab 62 HGS ETR2 62 PRX # 62 HCD# [002] 62 ACZ# 62 Phase Ia 62 abiraterone 62 FM VP4 62 corticosteroid dexamethasone 62 2DG 62 selective inhibition 62 anxiolytic 62 personalized immunotherapy 62 Dalbavancin 62 telomerase therapeutic 62 Tesmilifene 62 cardiac toxicity 62 trastuzumab DM1 T DM1 62 sorafenib Nexavar 62 crofelemer 62 RSD# 62 olaparib 62 REMUNE R 62 aleglitazar 62 targeting CD# 62 lenalidomide Revlimid R 62 sitaxsentan 62 Aliskiren 62 Denufosol 62 trospium 62 #D#C# 61 Tolvaptan 61 MyVax R 61 Bevasiranib 61 MVA MUC1 IL2 61 Valortim 61 Olaparib 61 Gefitinib 61 PrevOnco 61 tarenflurbil 61 IMC A# 61 apricitabine 61 Cetrorelix 61 Raptiva ® 61 Chemokine 61 Lorianne Masuoka MD 61 Anidulafungin 61 cancer immunotherapies 61 Afatinib 61 ASA# 61 trastuzumab Herceptin ® 61 Miraxion 61 Phase 1b clinical 61 Naproxcinod 61 Aurora kinase 61 Synavive 61 ThermoDox R 61 rituximab Rituxan 61 highly selective inhibitor 61 TASKi3 61 Aurora kinase inhibitors 61 ORMD 61 Adentri 61 EVIZON TM 61 potent anti angiogenic 61 preclinical pharmacokinetic 61 Debio 61 Hsp# inhibition 61 Ophena 61 glatiramer 61 TLR8 agonist 61 ImmunoVEX HSV2 61 CIMZIA TM 61 Dacogen injection 61 orBec 61 LymphoStat B TM 61 guanfacine extended release 61 Spiegelmer 61 PKC# 61 BLA filing 61 Ereska 61 PI3K/Akt pathway inhibitor 61 antifolates 61 JAK3 61 T#I [002] 61 florbetaben 61 GHRH 61 QVA# 61 NEUGENE 61 Asentar 61 oxypurinol 61 Tectin 61 Triapine R 61 NGX# 61 SERMs 61 IAP inhibitor 61 CCR2 61 BAY #-# 61 bendamustine 61 Increlex ® 61 MoxDuo IR 61 CB1 antagonists 61 multiple myeloma MM 61 tolevamer 61 Zingo TM 61 Fodosine 61 Gattex 61 atacicept 61 Civacir 61 LHRH antagonist 61 2A receptor agonist 61 levodopa induced dyskinesia 61 antiangiogenic activity 61 Kevetrin ™ 61 oral rivaroxaban 61 Preos 61 NXL# 61 aclidinium 61 humanized antibody 61 zafirlukast 61 PF # [001] 61 Telintra 61 A3 adenosine receptor 61 Ceflatonin R 61 novel histone deacetylase 61 treat premature ejaculation 61 anti neoplastic 61 Mycophenolate Mofetil 61 Nanobodies ® 61 DEB# 61 ataluren 61 nabilone 61 fostamatinib disodium 61 INCB# [002] 61 Emselex 61 HCV replicon 61 liposomal doxorubicin 61 relapsed MCL 61 NS#/#A protease 61 lapatinib Tykerb 61 Elagolix 61 Hedgehog inhibitor 61 Pagoclone 61 anti angiogenic agents 61 gemcitabine Gemzar ® 61 glucagon receptor 61 Theratope 61 BGC# 61 gamma secretase inhibitor 61 Phase Ib II 61 AERx iDMS 61 relapsed ALL 61 BRIM3 61 Marqibo TM 61 antitumour activity 61 torezolid 61 polymerase inhibitor 61 AeroLEF TM 61 VAPRISOL 61 antitumoral 61 randomized Phase IIb 61 5 HT4 receptor 61 neratinib 61 pegylated liposomal doxorubicin 61 PREOS 61 adecatumumab MT# 61 Lacosamide 61 STEDESA 61 pharmacokinetic interactions 61 HyACT 61 teduglutide 61 ZOLINZA 61 Enkephalin 61 JAK2 inhibitors 61 EGFR HER 61 Irinotecan 61 cilengitide 61 Phase III psoriasis 61 torsemide ER 61 class mGluR5 inhibitor 61 Dyloject TM 61 Anticalin ® 61 milatuzumab 61 PNP inhibitor 61 Phase IIa clinical 61 phase IIb 61 humanised monoclonal antibody 61 Sapacitabine 61 Hsp# Inhibitor 61 HSP# inhibitor 61 Akt inhibitor 61 CR# vcMMAE 61 relapsed ovarian cancer 61 rBChE 61 humanized monoclonal 61 Indomethacin 61 #ME# 61 Zenvia ™ 61 ulimorelin 61 IGF 1R inhibitor 61 neuroprotective properties 61 Fesoterodine 61 clevidipine 61 epothilone 61 alpha#beta# integrin 61 ProLindac 61 Natalizumab 61 AMPK activators 61 cytoprotective 61 novel peptide 61 novel oral anticoagulant 61 Xinlay 61 pharmacodynamic profile 61 Granulocyte Colony Stimulating Factor 61 interferon beta therapy 61 trabectedin 61 Iressa gefitinib 61 P#X# 61 Exelon Patch 61 Mirapexin 61 Rotigotine 61 Cipralex ® 61 Perifosine 61 viral kinetics 61 Prosaptide 61 Ozarelix 61 Onrigin 61 insulin sensitizer 61 INS# [001] 61 Maribavir 61 lomitapide 61 multi kinase inhibitor 61 gefitinib Iressa 61 humanised antibody 61 Panzem R 61 siRNA therapeutic 61 TYSABRI natalizumab 61 CTAP# Capsules 61 cardiotoxic 61 RhuDex R 61 trial evaluating PRX# 61 Nexavar sorafenib 61 Tocosol 61 Phase IIa trials 61 IMiDs R 61 talabostat 61 CANCIDAS 61 NB S# strontium malonate 61 urocortin 2 61 cytokine refractory 61 vivo validation 61 relapsed MM 61 prokinetic 61 oral ridaforolimus 61 plasma pharmacokinetics 61 Tocosol Paclitaxel 61 IFN Beta 61 Cethrin 61 ONTAK 61 Seliciclib 61 Fc fusion protein 61 interleukin IL -# 61 antisense inhibitors 61 Anacetrapib 61 investigational HCV polymerase 61 lixivaptan 61 Azixa 61 Vimpat R 61 Talactoferrin 61 CDK inhibitor 61 Candesartan 61 pharmacokinetic PK 61 antiangiogenic therapy 61 TheraCIM 61 Kamada AAT 61 Flutiform TM 61 MYDICAR 61 frovatriptan 61 isavuconazole 61 ACOMPLIA R 61 Aptivus ® 61 Onalta 61 GTC recombinant human 61 davunetide 61 selegiline 61 anti angiogenic therapy 61 Bapineuzumab 61 Dapagliflozin 60 Angiolix 60 Interferon beta 1a 60 Gleevec imatinib mesylate 60 Advagraf 60 Apoptone 60 MitoQ 60 CCR2 antagonists 60 phase IIb study 60 COMT inhibitors 60 PLX cells 60 Cladribine 60 arbaclofen 60 radezolid 60 immatics 60 Kevetrin 60 Noxafil 60 vinorelbine tartrate 60 Campath ® 60 schizophrenia CIAS 60 R roscovitine 60 Acapodene 60 cetuximab Erbitux ® 60 alemtuzumab Campath 60 Lpathomab 60 retaspimycin 60 cardiac repolarization 60 rilonacept 60 immunomodulatory properties 60 antiapoptotic 60 TKM PLK1 60 Phase III ADT 60 nucleoside analog 60 Laquinimod 60 recombinant enzyme 60 Dendreon Provenge 60 Genz # 60 TG# [001] 60 Phase Ib 60 Oasmia 60 PrevOnco ™ 60 ZACTIMA 60 HGS ETR1 60 OMP #R# 60 Cethrin R 60 alkylating agent 60 non nucleoside HCV 60 antiangiogenic 60 paclitaxel Taxol 60 PS# [001] 60 thetreatment 60 Telatinib 60 Personalized Immunotherapy 60 monoclonal anti 60 bicalutamide 60 anti androgen 60 cetuximab Erbitux 60 fulvestrant 60 Arikace 60 desvenlafaxine succinate 60 rasagiline tablets 60 phase Ib clinical 60 immunotherapeutic vaccine 60 goserelin 60 LHRH antagonists 60 RG# [001] 60 Myocet 60 Vimpat ® 60 ASM8 60 Vidaza azacitidine 60 Vaprisol 60 demethylating agents 60 CGRP 60 Aloxi injection 60 TOCOSOL Paclitaxel 60 STRIDE PD 60 MoxDuo ® IR 60 BAL# [001] 60 angiogenesis inhibition 60 immunomodulatory 60 BEXXAR 60 AQ4N 60 incyclinide 60 gonadotrophin releasing hormone GnRH 60 Apaziquone 60 lurasidone 60 acyclovir Lauriad R 60 tesofensine 60 pivotal bioequivalence 60 Keppra XR 60 IAP inhibitors 60 PTHrP 60 Troxatyl 60 Vectibix panitumumab 60 isoform selective 60 Aurora Kinase 60 PDE7 inhibitors